Literature DB >> 20498453

Stroke: working toward a prioritized world agenda.

Vladimir Hachinski1, Geoffrey A Donnan, Philip B Gorelick, Werner Hacke, Steven C Cramer, Markku Kaste, Marc Fisher, Michael Brainin, Alastair M Buchan, Eng H Lo, Brett E Skolnick, Karen L Furie, Graeme J Hankey, Miia Kivipelto, John Morris, Peter M Rothwell, Ralph L Sacco, Sidney C Smith, Yulun Wang, Alan Bryer, Gary A Ford, Costantino Iadecola, Sheila C O Martins, Jeff Saver, Veronika Skvortsova, Mark Bayley, Martin M Bednar, Pamela Duncan, Lori Enney, Seth Finklestein, Theresa A Jones, Lalit Kalra, Jeff Kleim, Ralph Nitkin, Robert Teasell, Cornelius Weiller, Bhupat Desai, Mark P Goldberg, Wolf-Dieter Heiss, Osmo Saarelma, Lee H Schwamm, Yukito Shinohara, Bhargava Trivedi, Nils Wahlgren, Lawrence K Wong, Antoine Hakim, Bo Norrving, Stephen Prudhomme, Natan M Bornstein, Stephen M Davis, Larry B Goldstein, Didier Leys, Jaakko Tuomilehto.   

Abstract

BACKGROUND AND
PURPOSE: The aim of the Synergium was to devise and prioritize new ways of accelerating progress in reducing the risks, effects, and consequences of stroke.
METHODS: Preliminary work was performed by 7 working groups of stroke leaders followed by a synergium (a forum for working synergistically together) with approximately 100 additional participants. The resulting draft document had further input from contributors outside the synergium.
RESULTS: Recommendations of the Synergium are: Basic Science, Drug Development and Technology: There is a need to develop: (1) New systems of working together to break down the prevalent "silo" mentality; (2) New models of vertically integrated basic, clinical, and epidemiological disciplines; and (3) Efficient methods of identifying other relevant areas of science. Stroke Prevention: (1) Establish a global chronic disease prevention initiative with stroke as a major focus. (2) Recognize not only abrupt clinical stroke, but subtle subclinical stroke, the commonest type of cerebrovascular disease, leading to impairments of executive function. (3) Develop, implement and evaluate a population approach for stroke prevention. (4) Develop public health communication strategies using traditional and novel (eg, social media/marketing) techniques. Acute Stroke Management: Continue the establishment of stroke centers, stroke units, regional systems of emergency stroke care and telestroke networks. Brain Recovery and Rehabilitation: (1) Translate best neuroscience, including animal and human studies, into poststroke recovery research and clinical care. (2) Standardize poststroke rehabilitation based on best evidence. (3) Develop consensus on, then implementation of, standardized clinical and surrogate assessments. (4) Carry out rigorous clinical research to advance stroke recovery. Into the 21st Century: Web, Technology and Communications: (1) Work toward global unrestricted access to stroke-related information. (2) Build centralized electronic archives and registries. Foster Cooperation Among Stakeholders (large stroke organizations, nongovernmental organizations, governments, patient organizations and industry) to enhance stroke care. Educate and energize professionals, patients, the public and policy makers by using a "Brain Health" concept that enables promotion of preventive measures.
CONCLUSIONS: To accelerate progress in stroke, we must reach beyond the current status scientifically, conceptually, and pragmatically. Advances can be made not only by doing, but ceasing to do. Significant savings in time, money, and effort could result from discontinuing practices driven by unsubstantiated opinion, unproven approaches, and financial gain. Systematic integration of knowledge into programs coupled with careful evaluation can speed the pace of progress.

Entities:  

Mesh:

Year:  2010        PMID: 20498453      PMCID: PMC3712843          DOI: 10.1161/STROKEAHA.110.586156

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  74 in total

Review 1.  Systems biology and its application to the understanding of neurological diseases.

Authors:  Pablo Villoslada; Lawrence Steinman; Sergio E Baranzini
Journal:  Ann Neurol       Date:  2009-02       Impact factor: 10.422

2.  Identifying stroke in the field. Prospective validation of the Los Angeles prehospital stroke screen (LAPSS).

Authors:  C S Kidwell; S Starkman; M Eckstein; K Weems; J L Saver
Journal:  Stroke       Date:  2000-01       Impact factor: 7.914

3.  Are the results of the extracranial-intracranial bypass trial generalizable?

Authors:  H J Barnett; D Sackett; D W Taylor; B Haynes; S J Peerless; I Meissner; V Hachinski; A Fox
Journal:  N Engl J Med       Date:  1987-03-26       Impact factor: 91.245

Review 4.  Biomarkers of recovery after stroke.

Authors:  Marie-Hélène Milot; Steven C Cramer
Journal:  Curr Opin Neurol       Date:  2008-12       Impact factor: 5.710

Review 5.  Prevention of chronic diseases: a call to action.

Authors:  Robert Beaglehole; Shah Ebrahim; Srinath Reddy; Janet Voûte; Steve Leeder
Journal:  Lancet       Date:  2007-12-11       Impact factor: 79.321

6.  Progressive increase in infarct size, neuroinflammation, and cognitive deficits in the presence of high levels of amyloid.

Authors:  Shawn N Whitehead; Guanliang Cheng; Vladimir C Hachinski; David F Cechetto
Journal:  Stroke       Date:  2007-10-25       Impact factor: 7.914

Review 7.  Stroke telemedicine.

Authors:  Bart M Demaerschalk; Madeline L Miley; Terri-Ellen J Kiernan; Bentley J Bobrow; Doren A Corday; Kay E Wellik; Maria I Aguilar; Timothy J Ingall; David W Dodick; Karina Brazdys; Tiffany C Koch; Michael P Ward; Phillip C Richemont
Journal:  Mayo Clin Proc       Date:  2009       Impact factor: 7.616

8.  The 2007 Feinberg lecture: a new road map for neuroprotection.

Authors:  Geoffrey A Donnan
Journal:  Stroke       Date:  2007-11-29       Impact factor: 7.914

9.  Collaborative models for translational neuroscience and rehabilitation research.

Authors:  Bruce H Dobkin
Journal:  Neurorehabil Neural Repair       Date:  2009-06-18       Impact factor: 3.919

10.  Nursing Roles within a Stroke Telemedicine Network.

Authors:  Terri-Ellen J Kiernan; Bart M Demaerschalk
Journal:  J Cent Nerv Syst Dis       Date:  2010-02-11
View more
  28 in total

Review 1.  Telemedicine or telephone consultation in patients with acute stroke.

Authors:  Bart M Demaerschalk
Journal:  Curr Neurol Neurosci Rep       Date:  2011-02       Impact factor: 5.081

2.  Stroke: recovery inhibitors under attack.

Authors:  Kevin Staley
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

3.  Author's reply to Page: "Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept".

Authors:  Edward Tobinick
Journal:  CNS Drugs       Date:  2013-05       Impact factor: 5.749

4.  Stroke research at a crossroad: asking the brain for directions.

Authors:  Costantino Iadecola; Josef Anrather
Journal:  Nat Neurosci       Date:  2011-10-26       Impact factor: 24.884

Review 5.  Stroke-related translational research.

Authors:  Louis R Caplan; Juan Arenillas; Steven C Cramer; Anne Joutel; Eng H Lo; James Meschia; Sean Savitz; Elizabeth Tournier-Lasserve
Journal:  Arch Neurol       Date:  2011-05-09

6.  Sex Disparities in Access to Acute Stroke Care: Can Telemedicine Mitigate this Effect?

Authors:  Catherine Wolff; Amelia K Boehme; Karen C Albright; Tzu-Ching Wu; Michael T Mullen; Charles C Branas; James C Grotta; Sean I Savitz; Brendan G Carr
Journal:  J Health Dispar Res Pract       Date:  2016

Review 7.  Using insights from behavioral economics and social psychology to help patients manage chronic diseases.

Authors:  Braden K Mogler; Suzanne B Shu; Craig R Fox; Noah J Goldstein; Ronald G Victor; José J Escarce; Martin F Shapiro
Journal:  J Gen Intern Med       Date:  2012-11-15       Impact factor: 5.128

Review 8.  The dementia of cardiac disease.

Authors:  Hurmina Muqtadar; Fernando D Testai; Philip B Gorelick
Journal:  Curr Cardiol Rep       Date:  2012-12       Impact factor: 2.931

Review 9.  Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke.

Authors:  Mark A Eckert; Quynh Vu; Kate Xie; Jingxia Yu; Wenbin Liao; Steven C Cramer; Weian Zhao
Journal:  J Cereb Blood Flow Metab       Date:  2013-06-12       Impact factor: 6.200

10.  Conceptual framework for establishing the African Stroke Organization.

Authors:  Rufus Akinyemi; Fred Sarfo; Foad Abd-Allah; Yomi Ogun; Mofou Belo; Patty Francis; M Bettencourt Mateus; Kathleen Bateman; Pamela Naidoo; Augustina Charway-Felli; Albert Akpalu; Kolawole Wahab; Christian Napon; Oyedunni Arulogun; Ad Adams Ebenezer; Gloria Ekeng; George Scola; Kolapo Hamzat; Stanley Zimba; Paul Macaire Ossou-Nguiet; Julius Ademokoya; Philip Adebayo; Biniyam Alemayehu Ayele; Deise Catamo Vaz; Godwin Ogbole; Patrice Barasukan; Rita Melifonwu; Ikenna Onwuekwe; Sarah Belson; Albertino Damasceno; Njideka Okubadejo; Alfred K Njamnshi; Julius Ogeng'o; Richard W Walker; Amadou Gallo Diop; Adesola Ogunniyi; Rajesh Kalaria; Peter Sandercock; Stephen Davis; Michael Brainin; Bruce Ovbiagele; Mayowa Owolabi
Journal:  Int J Stroke       Date:  2020-02-06       Impact factor: 5.266

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.